MaxLinear, Inc. Announces Fourth Quarter 2022 Financial Results
MaxLinear reported record net revenue of $290.6 million for Q4 2022, a 2% sequential increase and a 17% rise year-over-year. Fiscal year revenue surpassed $1 billion for the first time, with significant contributions from connectivity revenue, particularly from Wi-Fi products, which reached $105 million in Q4, up 27% sequentially and 99% year-over-year. GAAP diluted earnings per share increased to $0.38. Operating cash flow for the year was $388.7 million. The company projects Q1 2023 revenue between $240 million and $260 million. Management expressed optimism about long-term growth and upcoming acquisition of Silicon Motion.
- Q4 2022 net revenue of $290.6 million, up 2% sequentially and 17% YoY.
- FY 2022 revenue exceeded $1 billion for the first time.
- Connectivity revenue, particularly Wi-Fi, grew by 99% YoY in Q4.
- GAAP gross margin decreased to 56.2% from 58.6% in the previous quarter.
- GAAP operating expenses rose to $122.2 million, 42% of revenue.
-
Record net revenue of
in Q4, up$290.6 million 2% sequentially and up17% year-over-year -
FY22 revenue exceeded
for the first time in company history$1 billion -
Connectivity revenue, led by our Wi-Fi product offering, delivered
in Q4, up$105 million 27% sequentially and99% YoY
Fourth Quarter Financial Highlights
GAAP basis:
-
Net revenue was
, up$290.6 million 2% sequentially and up17% year-over-year. -
GAAP gross margin was
56.2% , compared to58.6% in the prior quarter, and57.2% in the year-ago quarter. -
GAAP operating expenses were
in the fourth quarter 2022, or$122.2 million 42% of net revenue, compared to in the prior quarter, or$115.5 million 40% of net revenue, and in the year-ago quarter, or$112.4 million 45% of net revenue. -
GAAP income from operations was
14% of revenue, compared to income from operations of18% in the prior quarter, and income from operations of12% in the year-ago quarter. -
Net cash flow provided by operating activities was
, compared to net cash flow provided by operating activities of$69.4 million in the prior quarter, and net cash flow provided by operating activities of$61.8 million in the year-ago quarter.$16.0 million -
GAAP diluted earnings per share was
, compared to diluted earnings per share of$0.38 in the prior quarter, and diluted earnings per share of$0.35 in the year-ago quarter.$0.35
Non-GAAP basis:
-
Non-GAAP gross margin was
59.6% . This compares to62.0% in the prior quarter, and61.7% in the year-ago quarter. -
Non-GAAP operating expenses were
, or$78.5 million 27% of revenue, compared to or$80.4 million 28% of revenue in the prior quarter, and or$75.9 million 31% of revenue in the year-ago quarter. -
Non-GAAP income from operations was
33% of revenue, compared to34% in the prior quarter, and31% in the year-ago quarter. -
Non-GAAP diluted earnings per share was
, compared to diluted earnings per share of$1.07 in the prior quarter, and diluted earnings per share of$1.05 in the year-ago quarter.$0.86
Fiscal Year 2022 Financial Highlights
-
Net revenue was
, up$1.1 billion 26% over fiscal 2021. -
GAAP gross margin was
58.0% , up from55.6% the prior year, and GAAP net income was , an increase of$125.0 million 198% from for 2021.$42.0 million -
Non-GAAP gross margin was
61.6% , up from60.5% the prior year, and non-GAAP net income was , a$342.2 million 59% increase from for 2021.$214.6 million -
Net cash flow provided by operating activities was
in 2022, compared to net cash flow provided by operating activities of$388.7 million in 2021.$168.2 million
Management Commentary
“In the fourth quarter, we continued our strong execution with revenue up
First Quarter 2023 Business Outlook
The company expects revenue in the first quarter 2023 to be approximately
-
GAAP gross margin of approximately
55% to58% ; -
Non-GAAP gross margin of approximately
59% to62% ; -
GAAP operating expenses of approximately
to$113 million ;$119 million -
Non-GAAP operating expenses of approximately
to$80 ;$86 million -
GAAP and non-GAAP interest and other expenses of approximately
; and$4 million - GAAP and non-GAAP diluted share count of 81 to 83 million.
Webcast and Conference Call
Cautionary Note Concerning Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others, statements concerning our future financial performance (including specifically our current guidance for first quarter 2023 revenue, and GAAP and non-GAAP gross margins, operating expenses, interest and other expenses, and diluted share counts; statements concerning the Company’s pending merger with
In addition to these risks and uncertainties, investors should review the risks and uncertainties contained in our filings with the
Use of Non-GAAP Financial Measures
To supplement our unaudited consolidated financial statements presented on a basis consistent with GAAP, we disclose certain non-GAAP financial measures, including non-GAAP gross margin, operating expenses, operating expenses as a percentage of revenue, income from operations as percentage of revenue, and diluted earnings per share. These supplemental measures exclude the effects of (i) stock-based compensation expense; (ii) accruals related to our performance based bonus plan for 2022, which we currently intend to settle in shares of our common stock; (iii) accruals related to our performance-based bonus plan for 2021, which we settled in shares of common stock in 2022; (iv) amortization of purchased intangible assets; (v) research and development funded by others; (vi) acquisition and integration costs related to our acquisitions; (vii) professional fees and settlement costs related to IP and commercial litigation matters; (viii) impairment of intangible assets; (ix) severance and other restructuring charges; (x) other non-recurring interest and other income (expenses), net attributable to acquisitions and (xi) non-cash income tax benefits and expenses. Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for the comparable GAAP financial measures. Non-GAAP financial measures are subject to limitations, and should be read only in conjunction with the company’s consolidated financial statements prepared in accordance with GAAP. Non-GAAP financial measures do not have any standardized meaning and are therefore unlikely to be comparable to similarly titled measures presented by other companies. We believe that these non-GAAP measures have limitations in that they do not reflect all of the amounts associated with our GAAP results of operations. We compensate for the limitations of non-GAAP financial measures by relying upon GAAP results to gain a complete picture of our performance.
We believe that non-GAAP financial measures can provide useful information to both management and investors by excluding certain non-cash and other one-time expenses that we believe are not indicative of our core operating results. Among other uses, our management uses non-GAAP measures to compare our performance relative to forecasts and strategic plans and to benchmark our performance externally against competitors. In addition, management’s incentive compensation will be determined in part using these non-GAAP measures because we believe non-GAAP measures better reflect our core operating performance.
The following are explanations of each type of adjustment that we incorporate into non-GAAP financial measures:
Stock-based compensation expense relates to equity incentive awards granted to our employees, directors, and consultants. Our equity incentive plans are important components of our employee incentive compensation arrangements and are reflected as expenses in our GAAP results. Stock-based compensation expense has been and will continue to be a significant recurring expense for
Bonuses under our executive and non-executive bonus programs have been excluded from our non-GAAP net income for all periods reported. Bonus payments for the 2021 performance periods were settled through the issuance of shares of common stock under our equity incentive plans in
Expenses incurred in relation to acquisitions include amortization of purchased intangible assets, acquisition and integration costs primarily consisting of professional and consulting fees, and accretion of discount on contingent consideration or deferred purchase price payments to interest expense.
Research and development funded by others represents proceeds received under contracts for jointly funded R&D projects to develop technology that may be commercialized into a product in the future. Initially such proceeds may not yet be recognized in GAAP results if, pursuant to contract terms, the Company may be required to repay all or a portion of the funds provided by the other party under certain conditions. Management believes it is not probable that it will trigger such conditions. Once such conditions have been resolved, the proceeds are recognized in GAAP results, and accordingly, reversed from non-GAAP results.
Impairment losses are related to abandonment of acquired or purchased intangible assets.
Restructuring charges incurred are related to our restructuring plans which eliminate redundancies and primarily include severance and restructuring costs related to impairment of leased right-of-use assets or from exiting certain facilities.
Expenses incurred in relation to our intellectual property and commercial litigation include professional fees incurred.
Income tax benefits and expense adjustments are those that do not affect cash income taxes payable.
Reconciliations of non-GAAP measures for the historic periods disclosed in this press release appear below. Because of the inherent uncertainty associated with our ability to project future charges, particularly related to stock-based compensation and its related tax effects as well as potential impairments, a quantitative reconciliation is not available without unreasonable efforts and accordingly we have not provided a reconciliation for non-GAAP guidance provided for the first quarter 2023.
Additional Information and Where to Find It
This press release makes reference to a proposed merger involving
The proxy statement/prospectus and this press release are not offers to sell
MAXLINEAR AND SILICON MOTION URGE INVESTORS AND SECURITY HOLDERS TO READ THE REGISTRATION STATEMENT ON FORM S-4 AND OTHER DOCUMENTS PROVIDED TO SILICON MOTION SECURITY HOLDERS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION.
Investors and security holders are able to obtain the Registration Statement on Form S-4 free of charge at the SEC’s website, www.sec.gov. Copies of documents filed with the
About
MXL is MaxLinear’s registered trademark. Other trademarks appearing herein are the property of their respective owners.
|
|||||||||||
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF INCOME |
|||||||||||
(in thousands, except per share data) |
|||||||||||
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
||||||
Net revenue |
$ |
290,586 |
|
|
$ |
285,730 |
|
|
$ |
247,889 |
|
Cost of net revenue |
|
127,246 |
|
|
|
118,242 |
|
|
|
106,112 |
|
Gross profit |
|
163,340 |
|
|
|
167,488 |
|
|
|
141,777 |
|
Operating expenses: |
|
|
|
|
|
||||||
Research and development |
|
73,724 |
|
|
|
76,437 |
|
|
|
73,320 |
|
Selling, general and administrative |
|
44,472 |
|
|
|
38,472 |
|
|
|
39,120 |
|
Impairment losses |
|
2,811 |
|
|
|
— |
|
|
|
— |
|
Restructuring charges |
|
1,172 |
|
|
|
631 |
|
|
|
— |
|
Total operating expenses |
|
122,179 |
|
|
|
115,540 |
|
|
|
112,440 |
|
Income from operations |
|
41,161 |
|
|
|
51,948 |
|
|
|
29,337 |
|
Interest income |
|
70 |
|
|
|
62 |
|
|
|
32 |
|
Interest expense |
|
(2,292 |
) |
|
|
(2,711 |
) |
|
|
(2,400 |
) |
Other income (expense), net |
|
1,774 |
|
|
|
(4,705 |
) |
|
|
1,510 |
|
Total other income (expense), net |
|
(448 |
) |
|
|
(7,354 |
) |
|
|
(858 |
) |
Income before income taxes |
|
40,713 |
|
|
|
44,594 |
|
|
|
28,479 |
|
Income tax provision |
|
9,633 |
|
|
|
16,186 |
|
|
|
303 |
|
Net income |
$ |
31,080 |
|
|
$ |
28,408 |
|
|
$ |
28,176 |
|
Net income per share: |
|
|
|
|
|
||||||
Basic |
$ |
0.40 |
|
|
$ |
0.36 |
|
|
$ |
0.37 |
|
Diluted |
$ |
0.38 |
|
|
$ |
0.35 |
|
|
$ |
0.35 |
|
Shares used to compute net income per share: |
|
|
|
|
|
||||||
Basic |
|
78,649 |
|
|
|
78,436 |
|
|
|
76,755 |
|
Diluted |
|
82,406 |
|
|
|
80,060 |
|
|
|
81,567 |
|
|
||||||||
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF INCOME |
||||||||
(in thousands, except per share data) |
||||||||
|
|
|
|
|
||||
|
|
Year Ended |
||||||
|
|
|
|
|
||||
Net revenue |
|
$ |
1,120,252 |
|
|
$ |
892,398 |
|
Cost of net revenue |
|
|
470,483 |
|
|
|
396,566 |
|
Gross profit |
|
|
649,769 |
|
|
|
495,832 |
|
Operating expenses: |
|
|
|
|
||||
Research and development |
|
|
296,442 |
|
|
|
278,440 |
|
Selling, general and administrative |
|
|
168,008 |
|
|
|
149,943 |
|
Impairment losses |
|
|
2,811 |
|
|
|
— |
|
Restructuring charges |
|
|
2,265 |
|
|
|
2,204 |
|
Total operating expenses |
|
|
469,526 |
|
|
|
430,587 |
|
Income from operations |
|
|
180,243 |
|
|
|
65,245 |
|
Interest income |
|
|
245 |
|
|
|
78 |
|
Interest expense |
|
|
(9,768 |
) |
|
|
(12,996 |
) |
Loss on extinguishment of debt |
|
|
— |
|
|
|
(5,221 |
) |
Other income (expense), net |
|
|
3,478 |
|
|
|
764 |
|
Total other income (expense), net |
|
|
(6,045 |
) |
|
|
(17,375 |
) |
Income before income taxes |
|
|
174,198 |
|
|
|
47,870 |
|
Income tax provision |
|
|
49,158 |
|
|
|
5,901 |
|
Net income |
|
$ |
125,040 |
|
|
$ |
41,969 |
|
Net income per share: |
|
|
|
|
||||
Basic |
|
$ |
1.60 |
|
|
$ |
0.55 |
|
Diluted |
|
$ |
1.55 |
|
|
$ |
0.53 |
|
Shares used to compute net income per share: |
|
|
|
|
||||
Basic |
|
|
78,039 |
|
|
|
76,037 |
|
Diluted |
|
|
80,852 |
|
|
|
79,679 |
|
|
|||||||||||
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||||||
(in thousands) |
|||||||||||
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
||||||
Operating Activities |
|
|
|
|
|
||||||
Net income |
$ |
31,080 |
|
|
$ |
28,408 |
|
|
$ |
28,176 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
||||||
Amortization and depreciation |
|
18,825 |
|
|
|
18,457 |
|
|
|
24,353 |
|
Impairment losses |
|
2,811 |
|
|
|
— |
|
|
|
— |
|
Amortization of debt issuance costs and accretion of discount on debt and leases |
|
513 |
|
|
|
505 |
|
|
|
416 |
|
Stock-based compensation |
|
23,550 |
|
|
|
20,131 |
|
|
|
16,415 |
|
Deferred income taxes |
|
133 |
|
|
|
15,962 |
|
|
|
(4,640 |
) |
Loss on disposal of property and equipment |
|
3 |
|
|
|
3 |
|
|
|
— |
|
Gain on sale of investments |
|
(3,375 |
) |
|
|
— |
|
|
|
— |
|
Unrealized holding loss on investments |
|
58 |
|
|
|
5,277 |
|
|
|
— |
|
(Gain) loss on foreign currency and other |
|
1,416 |
|
|
|
(570 |
) |
|
|
250 |
|
Excess tax benefits on stock based awards |
|
(219 |
) |
|
|
(273 |
) |
|
|
(2,046 |
) |
Changes in operating assets and liabilities: |
|
|
|
|
|
||||||
Accounts receivable |
|
7,101 |
|
|
|
(41,007 |
) |
|
|
(12,265 |
) |
Inventory |
|
5,426 |
|
|
|
(19,539 |
) |
|
|
(4,249 |
) |
Prepaid expenses and other assets |
|
(2,168 |
) |
|
|
2,129 |
|
|
|
(9,301 |
) |
Accounts payable, accrued expenses and other current liabilities |
|
(16,574 |
) |
|
|
19,768 |
|
|
|
(22,283 |
) |
Accrued compensation |
|
9,816 |
|
|
|
10,832 |
|
|
|
9,746 |
|
Accrued price protection liability |
|
(3,394 |
) |
|
|
6,171 |
|
|
|
(8,956 |
) |
Lease liabilities |
|
(2,955 |
) |
|
|
(2,974 |
) |
|
|
(2,835 |
) |
Other long-term liabilities |
|
(2,690 |
) |
|
|
(1,514 |
) |
|
|
3,252 |
|
Net cash provided by operating activities |
|
69,357 |
|
|
|
61,766 |
|
|
|
16,033 |
|
Investing Activities |
|
|
|
|
|
||||||
Purchases of property and equipment |
|
(16,628 |
) |
|
|
(9,119 |
) |
|
|
(12,242 |
) |
Purchases of intangible assets |
|
(744 |
) |
|
|
(5,236 |
) |
|
|
(965 |
) |
Cash used in acquisitions, net of cash acquired |
|
— |
|
|
|
— |
|
|
|
(5,000 |
) |
Purchases of investments |
|
— |
|
|
|
(1,000 |
) |
|
|
— |
|
Net cash used in investing activities |
|
(17,372 |
) |
|
|
(15,355 |
) |
|
|
(18,207 |
) |
Financing Activities |
|
|
|
|
|
||||||
Payment of debt issuance cost |
|
— |
|
|
|
— |
|
|
|
(29 |
) |
Repayment of debt |
|
(50,000 |
) |
|
|
(75,000 |
) |
|
|
(20,000 |
) |
Net proceeds from issuance of common stock |
|
1,792 |
|
|
|
81 |
|
|
|
2,494 |
|
Minimum tax withholding paid on behalf of employees for restricted stock units |
|
(369 |
) |
|
|
(380 |
) |
|
|
(2,068 |
) |
Repurchase of common stock |
|
— |
|
|
|
— |
|
|
|
(15,403 |
) |
Net cash used in financing activities |
|
(48,577 |
) |
|
|
(75,299 |
) |
|
|
(35,006 |
) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
|
2,456 |
|
|
|
(1,038 |
) |
|
|
(1,636 |
) |
Increase (decrease) in cash, cash equivalents and restricted cash |
|
5,864 |
|
|
|
(29,926 |
) |
|
|
(38,816 |
) |
Cash, cash equivalents and restricted cash at beginning of period |
|
182,493 |
|
|
|
212,419 |
|
|
|
170,554 |
|
Cash, cash equivalents and restricted cash at end of period |
$ |
188,357 |
|
|
$ |
182,493 |
|
|
$ |
131,738 |
|
|
||||||||
UNAUDITED GAAP CONSOLIDATED STATEMENTS OF CASH FLOWS |
||||||||
(in thousands) |
||||||||
|
|
|
|
|
||||
|
|
Year Ended |
||||||
|
|
|
|
|
||||
Operating Activities |
|
|
|
|
||||
Net income |
|
$ |
125,040 |
|
|
$ |
41,969 |
|
Adjustments to reconcile net income to cash provided by operating activities: |
|
|
|
|
||||
Amortization and depreciation |
|
|
80,731 |
|
|
|
91,792 |
|
Impairment losses |
|
|
2,811 |
|
|
|
— |
|
Amortization of debt issuance costs and accretion of discount on debt and leases |
|
|
1,975 |
|
|
|
3,000 |
|
Stock-based compensation |
|
|
81,704 |
|
|
|
59,358 |
|
Deferred income taxes |
|
|
23,454 |
|
|
|
(3,235 |
) |
Loss on disposal of property and equipment |
|
|
170 |
|
|
|
533 |
|
Gain on sale of investments |
|
|
(3,375 |
) |
|
|
— |
|
Unrealized holding loss on investments |
|
|
1,476 |
|
|
|
— |
|
Impairment of leasehold improvements |
|
|
— |
|
|
|
226 |
|
Impairment of leased right-of-use assets |
|
|
462 |
|
|
|
429 |
|
Loss on extinguishment of debt |
|
|
— |
|
|
|
5,221 |
|
(Gain) loss on foreign currency |
|
|
(1,829 |
) |
|
|
634 |
|
Excess tax benefits on stock-based awards |
|
|
(9,921 |
) |
|
|
(7,415 |
) |
Changes in operating assets and liabilities: |
|
|
|
|
||||
Accounts receivable |
|
|
(50,875 |
) |
|
|
(51,690 |
) |
Inventory |
|
|
(28,841 |
) |
|
|
(33,689 |
) |
Prepaid expenses and other assets |
|
|
1,789 |
|
|
|
24,186 |
|
Leased right-of-use assets |
|
|
— |
|
|
|
72 |
|
Accounts payable, accrued expenses and other current liabilities |
|
|
65,815 |
|
|
|
12,771 |
|
Accrued compensation |
|
|
42,003 |
|
|
|
33,595 |
|
Accrued price protection liability |
|
|
73,574 |
|
|
|
(7,320 |
) |
Lease liabilities |
|
|
(11,440 |
) |
|
|
(9,905 |
) |
Other long-term liabilities |
|
|
(5,997 |
) |
|
|
7,701 |
|
Net cash provided by operating activities |
|
|
388,726 |
|
|
|
168,233 |
|
Investing Activities |
|
|
|
|
||||
Purchases of property and equipment |
|
|
(41,253 |
) |
|
|
(39,176 |
) |
Purchases of intangible assets |
|
|
(11,184 |
) |
|
|
(7,581 |
) |
Cash used in acquisitions, net of cash acquired |
|
|
— |
|
|
|
(40,000 |
) |
Proceeds loaned under notes receivable |
|
|
(10,000 |
) |
|
|
— |
|
Purchases of investments |
|
|
(29,325 |
) |
|
|
(5,000 |
) |
Net cash used in investing activities |
|
|
(91,762 |
) |
|
|
(91,757 |
) |
Financing Activities |
|
|
|
|
||||
Proceeds from the issuance of debt |
|
|
— |
|
|
|
350,000 |
|
Payment of debt issuance cost |
|
|
— |
|
|
|
(4,173 |
) |
Repayment of debt |
|
|
(185,000 |
) |
|
|
(409,813 |
) |
Net proceeds from issuance of common stock |
|
|
5,006 |
|
|
|
8,780 |
|
Minimum tax withholding paid on behalf of employees for restricted stock units |
|
|
(28,896 |
) |
|
|
(13,149 |
) |
Repurchase of common stock |
|
|
(31,511 |
) |
|
|
(23,548 |
) |
Net cash used in financing activities |
|
|
(240,401 |
) |
|
|
(91,903 |
) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
|
|
56 |
|
|
|
(2,869 |
) |
Increase (decrease) in cash, cash equivalents and restricted cash |
|
|
56,619 |
|
|
|
(18,296 |
) |
Cash, cash equivalents and restricted cash at beginning of period |
|
|
131,738 |
|
|
|
150,034 |
|
Cash, cash equivalents and restricted cash at end of period |
|
$ |
188,357 |
|
|
$ |
131,738 |
|
|
||||||||
UNAUDITED GAAP CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||||
(in thousands) |
||||||||
|
|
|
|
|
|
|||
Assets |
|
|
|
|
|
|||
Current assets: |
|
|
|
|
|
|||
Cash and cash equivalents |
$ |
187,353 |
|
$ |
181,496 |
|
$ |
130,572 |
Short-term restricted cash |
|
982 |
|
|
971 |
|
|
105 |
Short-term investments |
|
18,529 |
|
|
18,587 |
|
|
— |
Accounts receivable, net |
|
170,971 |
|
|
178,072 |
|
|
119,724 |
Inventory |
|
160,544 |
|
|
165,970 |
|
|
131,703 |
Prepaid expenses and other current assets |
|
24,745 |
|
|
17,879 |
|
|
22,000 |
Total current assets |
|
563,124 |
|
|
562,975 |
|
|
404,104 |
Long-term restricted cash |
|
22 |
|
|
26 |
|
|
1,061 |
Property and equipment, net |
|
79,018 |
|
|
67,081 |
|
|
60,924 |
Leased right-of-use assets |
|
28,515 |
|
|
30,041 |
|
|
27,269 |
Intangible assets, net |
|
109,316 |
|
|
122,142 |
|
|
152,540 |
|
|
306,739 |
|
|
306,739 |
|
|
306,668 |
Deferred tax assets |
|
66,491 |
|
|
65,767 |
|
|
89,168 |
Other long-term assets |
|
26,800 |
|
|
27,927 |
|
|
8,650 |
Total assets |
$ |
1,180,025 |
|
$ |
1,182,698 |
|
$ |
1,050,384 |
|
|
|
|
|
|
|||
Liabilities and stockholders’ equity |
|
|
|
|
|
|||
Current liabilities |
$ |
341,086 |
|
$ |
351,318 |
|
$ |
207,395 |
Long-term lease liabilities |
|
23,353 |
|
|
25,040 |
|
|
24,640 |
Long-term debt |
|
121,757 |
|
|
171,607 |
|
|
306,153 |
Other long-term liabilities |
|
17,444 |
|
|
18,852 |
|
|
22,998 |
Stockholders’ equity |
|
676,385 |
|
|
615,881 |
|
|
489,198 |
Total liabilities and stockholders’ equity |
$ |
1,180,025 |
|
$ |
1,182,698 |
|
$ |
1,050,384 |
|
|||||||||||
UNAUDITED RECONCILIATION OF NON-GAAP ADJUSTMENTS |
|||||||||||
(in thousands, except per share data) |
|||||||||||
|
Three Months Ended |
||||||||||
|
|
|
|
|
|
||||||
GAAP gross profit |
$ |
163,340 |
|
|
$ |
167,488 |
|
|
$ |
141,777 |
|
Stock-based compensation |
|
222 |
|
|
|
188 |
|
|
|
152 |
|
Performance based equity |
|
175 |
|
|
|
136 |
|
|
|
137 |
|
Amortization of purchased intangible assets |
|
9,325 |
|
|
|
9,332 |
|
|
|
10,759 |
|
Non-GAAP gross profit |
|
173,062 |
|
|
|
177,144 |
|
|
|
152,825 |
|
|
|
|
|
|
|
||||||
GAAP R&D expenses |
|
73,724 |
|
|
|
76,437 |
|
|
|
73,320 |
|
Stock-based compensation |
|
(10,341 |
) |
|
|
(10,635 |
) |
|
|
(8,243 |
) |
Performance based equity |
|
(8,205 |
) |
|
|
(7,690 |
) |
|
|
(8,224 |
) |
Research and development funded by others |
|
(2,000 |
) |
|
|
(1,000 |
) |
|
|
(2,000 |
) |
Acquisition and integration costs |
|
— |
|
|
|
— |
|
|
|
(25 |
) |
Non-GAAP R&D expenses |
|
53,178 |
|
|
|
57,112 |
|
|
|
54,828 |
|
|
|
|
|
|
|
||||||
GAAP SG&A expenses |
|
44,472 |
|
|
|
38,472 |
|
|
|
39,120 |
|
Stock-based compensation |
|
(12,988 |
) |
|
|
(9,308 |
) |
|
|
(8,020 |
) |
Performance based equity |
|
(3,791 |
) |
|
|
(3,043 |
) |
|
|
(3,934 |
) |
Amortization of purchased intangible assets |
|
(1,312 |
) |
|
|
(1,541 |
) |
|
|
(5,928 |
) |
Acquisition and integration costs |
|
(1,069 |
) |
|
|
(1,278 |
) |
|
|
(192 |
) |
Non-GAAP SG&A expenses |
|
25,312 |
|
|
|
23,302 |
|
|
|
21,046 |
|
|
|
|
|
|
|
||||||
GAAP impairment losses |
|
2,811 |
|
|
|
— |
|
|
|
— |
|
Impairment losses |
|
(2,811 |
) |
|
|
— |
|
|
|
— |
|
Non-GAAP impairment losses |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
||||||
GAAP restructuring expenses |
|
1,172 |
|
|
|
631 |
|
|
|
— |
|
Restructuring charges |
|
(1,172 |
) |
|
|
(631 |
) |
|
|
— |
|
Non-GAAP restructuring expenses |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
||||||
GAAP income from operations |
|
41,161 |
|
|
|
51,948 |
|
|
|
29,337 |
|
Total non-GAAP adjustments |
|
53,411 |
|
|
|
44,782 |
|
|
|
47,614 |
|
Non-GAAP income from operations |
|
94,572 |
|
|
|
96,730 |
|
|
|
76,951 |
|
|
|
|
|
|
|
||||||
GAAP interest and other income (expense), net |
|
(448 |
) |
|
|
(7,354 |
) |
|
|
(858 |
) |
Non-recurring interest and other income (expense), net |
|
59 |
|
|
|
58 |
|
|
|
(1,893 |
) |
Non-GAAP interest and other income (expense), net |
|
(389 |
) |
|
|
(7,296 |
) |
|
|
(2,751 |
) |
|
|
|
|
|
|
||||||
GAAP income before income taxes |
|
40,713 |
|
|
|
44,594 |
|
|
|
28,479 |
|
Total non-GAAP adjustments |
|
53,470 |
|
|
|
44,840 |
|
|
|
45,721 |
|
Non-GAAP income before income taxes |
|
94,183 |
|
|
|
89,434 |
|
|
|
74,200 |
|
|
|
|
|
|
|
||||||
GAAP income tax provision |
|
9,633 |
|
|
|
16,186 |
|
|
|
303 |
|
Adjustment for non-cash tax benefits/expenses |
|
(3,982 |
) |
|
|
(10,820 |
) |
|
|
4,149 |
|
Non-GAAP income tax provision |
|
5,651 |
|
|
|
5,366 |
|
|
|
4,452 |
|
|
|
|
|
|
|
||||||
GAAP net income |
|
31,080 |
|
|
|
28,408 |
|
|
|
28,176 |
|
Total non-GAAP adjustments before income taxes |
|
53,470 |
|
|
|
44,840 |
|
|
|
45,721 |
|
Less: total tax adjustments |
|
(3,982 |
) |
|
|
(10,820 |
) |
|
|
4,149 |
|
Non-GAAP net income |
$ |
88,532 |
|
|
$ |
84,068 |
|
|
$ |
69,748 |
|
|
|
|
|
|
|
||||||
Shares used in computing non-GAAP basic net income per share |
|
78,649 |
|
|
|
78,436 |
|
|
|
76,755 |
|
Shares used in computing non-GAAP diluted net income per share |
|
82,406 |
|
|
|
80,060 |
|
|
|
81,567 |
|
Non-GAAP basic net income per share |
$ |
1.13 |
|
|
$ |
1.07 |
|
|
$ |
0.91 |
|
Non-GAAP diluted net income per share |
$ |
1.07 |
|
|
$ |
1.05 |
|
|
$ |
0.86 |
|
||||||||
UNAUDITED RECONCILIATION OF NON-GAAP ADJUSTMENTS |
||||||||
(in thousands, except per share data) |
||||||||
|
|
|
|
|
||||
|
|
Year Ended |
||||||
|
|
|
|
|
||||
GAAP gross profit |
|
$ |
649,769 |
|
|
$ |
495,832 |
|
Stock-based compensation |
|
|
735 |
|
|
|
620 |
|
Performance based equity |
|
|
569 |
|
|
|
469 |
|
Amortization of purchased intangible assets |
|
|
39,288 |
|
|
|
42,992 |
|
Non-GAAP gross profit |
|
|
690,361 |
|
|
|
539,913 |
|
|
|
|
|
|
||||
GAAP R&D expenses |
|
|
296,442 |
|
|
|
278,440 |
|
Stock-based compensation |
|
|
(40,635 |
) |
|
|
(30,364 |
) |
Performance based equity |
|
|
(28,463 |
) |
|
|
(27,713 |
) |
Research and development funded by others |
|
|
(2,200 |
) |
|
|
(5,800 |
) |
Acquisition and integration costs |
|
|
— |
|
|
|
(155 |
) |
Non-GAAP R&D expenses |
|
|
225,144 |
|
|
|
214,408 |
|
|
|
|
|
|
||||
GAAP SG&A expenses |
|
|
168,008 |
|
|
|
149,943 |
|
Stock-based compensation |
|
|
(40,335 |
) |
|
|
(28,374 |
) |
Performance based equity |
|
|
(11,610 |
) |
|
|
(12,301 |
) |
Amortization of purchased intangible assets |
|
|
(11,955 |
) |
|
|
(23,625 |
) |
Acquisition and integration costs |
|
|
(8,711 |
) |
|
|
(1,913 |
) |
IP litigation costs, net |
|
|
— |
|
|
|
(11 |
) |
Non-GAAP SG&A expenses |
|
|
95,397 |
|
|
|
83,719 |
|
|
|
|
|
|
||||
GAAP impairment losses |
|
|
2,811 |
|
|
|
— |
|
Impairment losses |
|
|
(2,811 |
) |
|
|
— |
|
Non-GAAP impairment losses |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
||||
GAAP restructuring expenses |
|
|
2,265 |
|
|
|
2,204 |
|
Restructuring charges |
|
|
(2,265 |
) |
|
|
(2,204 |
) |
Non-GAAP restructuring expenses |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
||||
GAAP income from operations |
|
|
180,243 |
|
|
|
65,245 |
|
Total non-GAAP adjustments |
|
|
189,577 |
|
|
|
176,541 |
|
Non-GAAP income from operations |
|
|
369,820 |
|
|
|
241,786 |
|
|
|
|
|
|
||||
GAAP income (loss) on extinguishment of debt |
|
|
— |
|
|
|
(5,221 |
) |
Loss on extinguishment of debt |
|
|
— |
|
|
|
5,221 |
|
Non-GAAP loss on extinguishment of debt |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
||||
GAAP interest and other income (expense), net |
|
|
(6,045 |
) |
|
|
(12,154 |
) |
Non-recurring interest and other income (expense), net |
|
|
241 |
|
|
|
(1,377 |
) |
Non-GAAP interest and other income (expense), net |
|
|
(5,804 |
) |
|
|
(13,531 |
) |
|
|
|
|
|
||||
GAAP income before income taxes |
|
|
174,198 |
|
|
|
47,870 |
|
Total non-GAAP adjustments |
|
|
189,818 |
|
|
|
180,385 |
|
Non-GAAP income before income taxes |
|
|
364,016 |
|
|
|
228,255 |
|
|
|
|
|
|
||||
GAAP income tax provision |
|
|
49,158 |
|
|
|
5,901 |
|
Adjustment for non-cash tax benefits/expenses |
|
|
(27,317 |
) |
|
|
7,794 |
|
Non-GAAP income tax provision |
|
|
21,841 |
|
|
|
13,695 |
|
|
|
|
|
|
||||
GAAP net income |
|
|
125,040 |
|
|
|
41,969 |
|
Total non-GAAP adjustments before income taxes |
|
|
189,818 |
|
|
|
180,385 |
|
Less: total tax adjustments |
|
|
(27,317 |
) |
|
|
7,794 |
|
Non-GAAP net income |
|
$ |
342,175 |
|
|
$ |
214,560 |
|
|
|
|
|
|
||||
Shares used in computing non-GAAP basic net income per share |
|
|
78,039 |
|
|
|
76,037 |
|
Shares used in computing non-GAAP diluted net income per share |
|
|
80,852 |
|
|
|
79,679 |
|
Non-GAAP basic net income per share |
|
$ |
4.38 |
|
|
$ |
2.82 |
|
Non-GAAP diluted net income per share |
|
$ |
4.23 |
|
|
$ |
2.69 |
|
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES |
||||||||
|
Three Months Ended |
|||||||
|
|
|
|
|
|
|||
GAAP gross profit |
56.2 |
% |
|
58.6 |
% |
|
57.2 |
% |
Stock-based compensation |
0.1 |
% |
|
0.1 |
% |
|
0.1 |
% |
Performance based equity |
0.1 |
% |
|
0.1 |
% |
|
0.1 |
% |
Amortization of purchased intangible assets |
3.2 |
% |
|
3.3 |
% |
|
4.3 |
% |
Non-GAAP gross profit |
59.6 |
% |
|
62.0 |
% |
|
61.7 |
% |
|
|
|
|
|
|
|||
GAAP R&D expenses |
25.4 |
% |
|
26.8 |
% |
|
29.6 |
% |
Stock-based compensation |
(3.6 |
)% |
|
(3.7 |
)% |
|
(3.3 |
)% |
Performance based equity |
(2.8 |
)% |
|
(2.7 |
)% |
|
(3.3 |
)% |
Research and development funded by others |
(0.7 |
)% |
|
(0.4 |
)% |
|
(0.8 |
)% |
Non-GAAP R&D expenses |
18.3 |
% |
|
20.0 |
% |
|
22.1 |
% |
|
|
|
|
|
|
|||
GAAP SG&A expenses |
15.3 |
% |
|
13.5 |
% |
|
15.8 |
% |
Stock-based compensation |
(4.5 |
)% |
|
(3.3 |
)% |
|
(3.2 |
)% |
Performance based equity |
(1.3 |
)% |
|
(1.1 |
)% |
|
(1.6 |
)% |
Amortization of purchased intangible assets |
(0.5 |
)% |
|
(0.5 |
)% |
|
(2.4 |
)% |
Acquisition and integration costs |
(0.4 |
)% |
|
(0.5 |
)% |
|
(0.1 |
)% |
Non-GAAP SG&A expenses |
8.7 |
% |
|
8.2 |
% |
|
8.5 |
% |
|
|
|
|
|
|
|||
GAAP impairment losses |
1.0 |
% |
|
— |
% |
|
— |
% |
Impairment losses |
(1.0 |
)% |
|
— |
% |
|
— |
% |
Non-GAAP impairment losses |
— |
% |
|
— |
% |
|
— |
% |
|
|
|
|
|
|
|||
GAAP restructuring expenses |
0.4 |
% |
|
0.2 |
% |
|
— |
% |
Restructuring charges |
(0.4 |
)% |
|
(0.2 |
)% |
|
— |
% |
Non-GAAP restructuring expenses |
— |
% |
|
— |
% |
|
— |
% |
|
|
|
|
|
|
|||
GAAP income from operations |
14.2 |
% |
|
18.2 |
% |
|
11.8 |
% |
Total non-GAAP adjustments |
18.4 |
% |
|
15.7 |
% |
|
19.2 |
% |
Non-GAAP income from operations |
32.5 |
% |
|
33.9 |
% |
|
31.0 |
% |
|
|
|
|
|
|
|||
GAAP interest and other income (expense), net |
(0.2 |
)% |
|
(2.6 |
)% |
|
(0.4 |
)% |
Non-recurring interest and other income (expense), net |
— |
% |
|
— |
% |
|
(0.8 |
)% |
Non-GAAP interest and other income (expense), net |
(0.1 |
)% |
|
(2.6 |
)% |
|
(1.1 |
)% |
|
|
|
|
|
|
|||
GAAP income before income taxes |
14.0 |
% |
|
15.6 |
% |
|
11.5 |
% |
Total non-GAAP adjustments before income taxes |
18.4 |
% |
|
15.7 |
% |
|
18.4 |
% |
Non-GAAP income before income taxes |
32.4 |
% |
|
31.3 |
% |
|
29.9 |
% |
|
|
|
|
|
|
|||
GAAP income tax provision |
3.3 |
% |
|
5.7 |
% |
|
0.1 |
% |
Adjustment for non-cash tax benefits/expenses |
(1.4 |
)% |
|
(3.8 |
)% |
|
1.7 |
% |
Non-GAAP income tax provision |
1.9 |
% |
|
1.9 |
% |
|
1.8 |
% |
|
|
|
|
|
|
|||
GAAP net income |
10.7 |
% |
|
9.9 |
% |
|
11.4 |
% |
Total non-GAAP adjustments before income taxes |
18.4 |
% |
|
15.7 |
% |
|
18.4 |
% |
Less: total tax adjustments |
(1.4 |
)% |
|
(3.8 |
)% |
|
1.7 |
% |
Non-GAAP net income |
30.5 |
% |
|
29.4 |
% |
|
28.1 |
% |
|
||||||
UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES |
||||||
|
|
|
|
|
||
|
|
Year Ended |
||||
|
|
|
|
|
||
GAAP gross profit |
|
58.0 |
% |
|
55.6 |
% |
Stock-based compensation |
|
0.1 |
% |
|
0.1 |
% |
Performance based equity |
|
0.1 |
% |
|
0.1 |
% |
Amortization of purchased intangible assets |
|
3.5 |
% |
|
4.8 |
% |
Non-GAAP gross profit |
|
61.6 |
% |
|
60.5 |
% |
|
|
|
|
|
||
GAAP R&D expenses |
|
26.5 |
% |
|
31.2 |
% |
Stock-based compensation |
|
(3.6 |
)% |
|
(3.4 |
)% |
Performance based equity |
|
(2.5 |
)% |
|
(3.1 |
)% |
Research and development funded by others |
|
(0.2 |
)% |
|
(0.7 |
)% |
Acquisition and integration costs |
|
— |
% |
|
— |
% |
Non-GAAP R&D expenses |
|
20.1 |
% |
|
24.0 |
% |
|
|
|
|
|
||
GAAP SG&A expenses |
|
15.0 |
% |
|
16.8 |
% |
Stock-based compensation |
|
(3.6 |
)% |
|
(3.2 |
)% |
Performance based equity |
|
(1.0 |
)% |
|
(1.4 |
)% |
Amortization of purchased intangible assets |
|
(1.1 |
)% |
|
(2.7 |
)% |
Acquisition and integration costs |
|
(0.8 |
)% |
|
(0.2 |
)% |
Non-GAAP SG&A expenses |
|
8.5 |
% |
|
9.4 |
% |
|
|
|
|
|
||
GAAP impairment losses |
|
0.3 |
% |
|
— |
% |
Impairment losses |
|
(0.3 |
)% |
|
— |
% |
Non-GAAP impairment losses |
|
— |
% |
|
— |
% |
|
|
|
|
|
||
GAAP restructuring expenses |
|
0.2 |
% |
|
0.3 |
% |
Restructuring charges |
|
(0.2 |
)% |
|
(0.3 |
)% |
Non-GAAP restructuring expenses |
|
(0.2 |
)% |
|
— |
% |
|
|
|
|
|
||
GAAP income from operations |
|
16.1 |
% |
|
7.3 |
% |
Total non-GAAP adjustments |
|
16.9 |
% |
|
19.8 |
% |
Non-GAAP income from operations |
|
33.0 |
% |
|
27.1 |
% |
|
|
|
|
|
||
GAAP income (loss) on extinguishment of debt |
|
— |
% |
|
(0.6 |
)% |
Loss on extinguishment of debt |
|
— |
% |
|
0.6 |
% |
Non-GAAP loss on extinguishment of debt |
|
— |
% |
|
— |
% |
|
|
|
|
|
||
GAAP interest and other income (expense), net |
|
(0.5 |
)% |
|
(1.4 |
)% |
Non-recurring interest and other income (expense), net |
|
— |
% |
|
(0.2 |
)% |
Non-GAAP interest and other income (expense), net |
|
(0.5 |
)% |
|
(1.5 |
)% |
|
|
|
|
|
||
GAAP income before income taxes |
|
15.6 |
% |
|
5.4 |
% |
Total non-GAAP adjustments |
|
16.9 |
% |
|
20.2 |
% |
Non-GAAP income before income taxes |
|
32.5 |
% |
|
25.6 |
% |
|
|
|
|
|
||
GAAP income tax provision |
|
4.4 |
% |
|
0.7 |
% |
Adjustment for non-cash tax benefits/expenses |
|
(2.4 |
)% |
|
0.9 |
% |
Non-GAAP income tax provision |
|
2.0 |
% |
|
1.5 |
% |
|
|
|
|
|
||
GAAP net income |
|
11.2 |
% |
|
4.7 |
% |
Total non-GAAP adjustments before income taxes |
|
16.9 |
% |
|
20.2 |
% |
Less: total tax adjustments |
|
(2.4 |
)% |
|
0.9 |
% |
Non-GAAP net income |
|
30.5 |
% |
|
24.0 |
% |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230201005971/en/
Tel: +1 650-312-9060
lgreen@maxlinear.com
Source:
FAQ
What was MaxLinear's net revenue for Q4 2022?
How much did MaxLinear earn in the fiscal year 2022?
What is the projected revenue for MaxLinear in Q1 2023?
What were MaxLinear's GAAP diluted earnings per share for Q4 2022?